Contralateral risk reducing mastectomy - The Manchester experience

7 downloads 0 Views 37KB Size Report
mastectomy in larger ptotic patients who were unsuitable for autologous based reconstruction. An invitation letter was sent out to patients by mail along with the ...
618 mastectomy in larger ptotic patients who were unsuitable for autologous based reconstruction. An invitation letter was sent out to patients by mail along with the questionnaire. The Breast-Q (reconstruction module) scores were evaluated and compared to the British National Mastectomy & Breast Reconstruction Audit 2011 (NMBRA). Results: Fourteen out of 17 patients (82% response rate) completed the Breast-Q questionnaire with a median follow up of 27 months. 87% of patients were satisfied with the overall outcome, with satisfaction scores of 78% for breast outcome, 89% for psychosocial, 74% for sexual well-being and 85% for physical well-being. Satisfaction with the competence of the surgeon and the medical staff was 96% and 100% respectively with 86% happy with the amount of information available to them. This compares favourably against the results of the NMBRA. Conclusion: The inferior dermal flap is often utilised in the most complex scenarios. We have found that patients are highly satisfied with this form of one stage immediate reconstruction. http://dx.doi.org/10.1016/j.ejso.2014.02.029

P030. The availability of mammotome biopsy in UK breast units: Results of a national questionnaire study Kaustuv Das, Jill Donnelly, Iqbal Kasana Hereford County Hospital, Hereford, UK Introduction: This study aimed to assess the availability of mammotome biopsy (MB) or equivalent in breast units across the UK. Methods: Questionnaires were sent to breast surgeons in 231 breast units. They were asked cancer numbers treated annually, access to MB locally or elsewhere and procedure waiting times. Responses were stratified according to cancer numbers. Results: Responses were received from 170 breast units (73.6% response rate). Overall 106 (62%) units offer local MB. Of those who don’t, 47 (73.4%) refer patients elsewhere for the procedure. Of those with local MB, 85(80%) waited < 2 weeks for their procedure. Of those without and referred elsewhere, 15 (32%) waited < 2 weeks, 26 (55.3%) waited 2-4 weeks. See table:

Cancers / Units with access No local MB, Waiting time year to local MB referred elsewhere Local MB / MB elsewhere / Weeks Yes No Yes No 4 < 200 6 21 16 5 3/8 1/ 7 1 / 1 200 - 400 60 37 26 11 49 / 7 6 / 16 0 / 2 > 400 40 6 5 1 33 / 0 2 / 3 0/ 2 Totals 106 64 47 17 85/15 9/26 1/5 Conclusions: The majority of units have access to local MB. For those who do not and refer elsewhere waiting times are generally several weeks longer. Apparently for a small minority (10%) MB remains inaccessible.

ABSTRACTS in the US, with limited UK data. We describe our experience of CRRM from one of the largest units in the country. Method: Consecutive CRRMs were assessed over a 3-year period (2009-2012). Contralateral breast cancer (CBC) risk was calculated based on mutation status, family history and cancer biology. We stratified the different risk-groups, observing trends in reasons for requesting CRRM, reconstructive options, access to different healthcare professionals and previous attempts at breast conservation. Result: 67 patients underwent CRRM. Ages varied from 23-71 years (mean 43.8). Half the patients were in the high-risk group (>1:3 chance of developing CBC) compared to 40% in the low-risk group (